These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8049863)

  • 41. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
    Ericsson A; Bach-Gansmo T; Niklasson F; Hemmingsson A
    Acta Radiol; 1995 Jan; 36(1):41-6. PubMed ID: 7833167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concepts of myocardial perfusion imaging in magnetic resonance imaging.
    Wilke N; Jerosch-Herold M; Stillman AE; Kroll K; Tsekos N; Merkle H; Parrish T; Hu X; Wang Y; Bassingthwaighte J
    Magn Reson Q; 1994 Dec; 10(4):249-86. PubMed ID: 7873354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Quantitative evaluation of myocardial perfusion with ultrafast magnetic resonance tomography].
    Machnig T; Koroneos A; Engels G; Bachmann K; Simm C; Wilke N; Ellermann J; Zhang J; Ya X; Merkel H
    Z Kardiol; 1994 Nov; 83(11):840-50. PubMed ID: 7825374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods.
    Larsson HB; Tofts PS
    Magn Reson Med; 1992 Mar; 24(1):174-6. PubMed ID: 1556924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted Turbo-FLASH imaging.
    Dean BL; Lee C; Kirsch JE; Runge VM; Dempsey RM; Pettigrew LC
    AJNR Am J Neuroradiol; 1992; 13(1):39-48. PubMed ID: 1595482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rapid interleaved method for measuring signal intensity curves in both blood and tissue during contrast agent administration.
    Taylor NJ; Rowland IJ; Tanner SF; Leach MO
    Magn Reson Med; 1993 Dec; 30(6):744-9. PubMed ID: 8139457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved method for in vivo magnetic resonance contrast media research.
    Schmiedl UP; Maravilla KR; Nelson JA
    Invest Radiol; 1991 Jan; 26(1):65-70. PubMed ID: 2022455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contrast medium enhanced MR angiography].
    Vogl TJ; Hoffmann Y; Mühler A; Felix R
    Radiologe; 1994 Aug; 34(8):423-9. PubMed ID: 7972719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
    Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
    Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental evaluation of contrast medium enhanced high resolution MR angiography in the animal model. Gd-DTPA compared with Gd-DTPA-polylysine].
    Vogl TJ; Hoffmann Y; Juergens M; Weinmann HJ; Mühler A; Yucel S; Felix R
    Radiologe; 1996 Mar; 36(3):254-62. PubMed ID: 8693090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
    Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
    Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gd-DTPA in the diagnosis of brain metastasis].
    Kornienko VN; Pronin IN
    Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.
    Wilkins DE; Raaphorst GP; Saunders JK; Sutherland GR; Smith IC
    Magn Reson Imaging; 1995; 13(1):89-96. PubMed ID: 7898284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
    Schmitz SA; Mühler A; Wagner S; Wolf KJ
    Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gadolinium-DTPA enhanced MRI demonstrates uterine vascular changes associated with artificially induced decidualization and ovoimplantation in rats.
    Hamilton GS; Kennedy TG; Norley CJ; Karlik SJ
    Magn Reson Med; 1993 Jun; 29(6):817-21. PubMed ID: 8350726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma.
    Sijens PE; van Dijk P; Oudkerk M
    Magn Reson Med; 1994 Nov; 32(5):549-55. PubMed ID: 7808255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of lanthanide-based starch particles as a model system for liver contrast agents.
    Fossheim SL; Kellar KE; Mansson S; Colet JM; Rongved P; Fahlvik AK; Klaveness J
    J Magn Reson Imaging; 1999 Feb; 9(2):295-303. PubMed ID: 10077028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
    White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
    Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.